Mediar Therapeutics, Inc., a clinical-stage biotechnology company pioneering first-in-class therapies to halt and reverse ...
Susie Rider has raised $700K for cystic fibrosis research since her daughter was diagnosed with the disease 25 years ago.
Researchers at Tulane University have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people ...
Could next-generation gene editing mean a cure for cystic fibrosis (CF)? There's been a lot of advancement on the disease in the last decade, but there are still those living with the disease who get ...
The phase 2a MYLOX-1 trial demonstrated fibrosis reduction in some patients with myelofibrosis who previously received treatment with Jakafi (ruxolitinib). A phase 2a trial of novel monotherapy GB2064 ...
Cystic fibrosis affects many parts of the body, but its effects on the lungs can be especially harmful. Cystic fibrosis is a chronic and progressive condition that causes the mucus in your lungs to be ...
Cystic fibrosis is one of many conditions that can be screened for during prenatal genetic testing. For individuals with cystic fibrosis, or for those who may be wondering if they are a carrier, there ...
Discover IIT Madras researchers' innovative hydrogel treatment for fibrosis in The Health Wrap's latest episode.
The year 2024 is now underway. After a busy 2023, we’re now looking back at some of the oncology headlines from the new year. The year 2024 is now underway. After a busy 2023, we’re now looking back ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results